Ignite Creation Date:
2024-05-06 @ 5:59 PM
Last Modification Date:
2024-10-26 @ 2:39 PM
Study NCT ID:
NCT05507580
Status:
COMPLETED
Last Update Posted:
2024-01-26
First Post:
2022-08-18
Brief Title:
A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis
Sponsor:
AbbVie
Organization:
AbbVie
Organization Data
Organization:
AbbVie
Class:
INDUSTRY
Study ID:
M22-000
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AbbVie
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None